|
Market Closed -
Euronext Paris
11:55:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 7.760 EUR | +2.11% |
|
+1.57% | +24.16% |
| Market Cap | 42.81M 49.97M 40.05M 36.66M 68.81M 4.78B 69.72M 473M 185M 2.4B 188M 184M 7.94B | P/E 2026 * |
-19.5x | P/E 2027 * | 190x |
|---|---|---|---|---|---|
| Enterprise Value | 41.31M 48.22M 38.65M 35.38M 66.4M 4.61B 67.28M 457M 178M 2.32B 181M 177M 7.67B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 2.62x |
| Free-Float |
14.95% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.11% | ||
| 1 week | +1.57% | ||
| Current month | +0.78% | ||
| 1 month | -6.95% | ||
| 3 months | -13.78% | ||
| 6 months | +15.82% | ||
| Current year | +24.16% |
| 1 week | 7.54 | 7.76 | |
| 1 month | 7.02 | 8.4 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.9 | 9.1 | |
| 3 years | 2.25 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2008-12-28 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 2022-05-31 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 2020-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.11% | +1.57% | +22.20% | +218.03% | 50M | ||
| +0.88% | +6.38% | +76.86% | +128.23% | 1,109B | ||
| +1.07% | +3.80% | +51.03% | +61.48% | 644B | ||
| +1.20% | +6.21% | +26.47% | +76.45% | 463B | ||
| +1.02% | +3.67% | +43.14% | +47.27% | 371B | ||
| +0.85% | +2.97% | +24.48% | +42.54% | 301B | ||
| +1.26% | +4.54% | +2.20% | +14.84% | 256B | ||
| +1.88% | +5.81% | +48.54% | +68.52% | 234B | ||
| +1.59% | +0.87% | -12.95% | -51.91% | 205B | ||
| +1.87% | +5.61% | +25.81% | +92.42% | 178B | ||
| Average | +1.25% | +2.65% | +30.78% | +69.79% | 376.11B | |
| Weighted average by Cap. | +1.06% | +3.26% | +44.58% | +72.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11M 12.84M 10.29M 9.42M 17.68M 1.23B 17.92M 122M 47.42M 617M 48.22M 47.17M 2.04B | 16M 18.68M 14.97M 13.7M 25.72M 1.79B 26.06M 177M 68.98M 898M 70.14M 68.61M 2.97B |
| Net income | -2.25M -2.63M -2.11M -1.93M -3.62M -251M -3.66M -24.87M -9.7M -126M -9.86M -9.65M -418M | 250K 292K 234K 214K 402K 27.92M 407K 2.76M 1.08M 14.03M 1.1M 1.07M 46.4M |
| Net Debt | -1.5M -1.75M -1.4M -1.28M -2.41M -168M -2.44M -16.58M -6.47M -84.17M -6.58M -6.43M -278M | -900K -1.05M -842K -771K -1.45M -101M -1.47M -9.95M -3.88M -50.5M -3.95M -3.86M -167M |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €7.760 | +2.11% | 447 |
| 26-08-20 | €7.600 | +0.26% | 120 |
| 26-08-19 | €7.580 | +0.53% | 5 |
| 26-08-18 | €7.540 | 0.00% | 922 |
| 26-08-17 | €7.540 | -1.31% | 1,318 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.760EUR
Average target price
8.200EUR
Spread / Average Target
+5.67%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions
















